▶ 調査レポート

緑内障用医薬品の世界市場レポート2020

• 英文タイトル:Global Glaucoma Pharmaceutical Sales Market Report 2020

が調査・発行した産業分析レポートです。緑内障用医薬品の世界市場レポート2020 / Global Glaucoma Pharmaceutical Sales Market Report 2020 / MRC2102QY5894資料のイメージです。• レポートコード:MRC2102QY5894
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の緑内障用医薬品市場について種類別(縮瞳薬、ベータ遮断薬、アドレナリン作動薬、炭酸脱水酵素阻害薬、プロスタグランジン誘導体剤、ペネトレート)、用途別(病院薬局、ドラッグストア、オンライン販売)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・緑内障用医薬品市場の概要
・世界の主要地域別緑内障用医薬品市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の緑内障用医薬品市場規模2015-2026:種類別(縮瞳薬、ベータ遮断薬、アドレナリン作動薬、炭酸脱水酵素阻害薬、プロスタグランジン誘導体剤、ペネトレート)
・世界の緑内障用医薬品市場規模2015-2026:用途別(病院薬局、ドラッグストア、オンライン販売)
・緑内障用医薬品の米国市場規模2015-2020
・緑内障用医薬品のヨーロッパ市場規模2015-2020
・緑内障用医薬品の中国市場規模2015-2020
・緑内障用医薬品の日本市場規模2015-2020
・緑内障用医薬品の東南アジア市場規模2015-2020
・緑内障用医薬品のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・緑内障用医薬品の製造コスト分析
・販売チャネル、流通業者、顧客
・緑内障用医薬品の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Glaucoma Pharmaceutical Market
The global Glaucoma Pharmaceutical market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Glaucoma Pharmaceutical Scope and Market Size
The global Glaucoma Pharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glaucoma Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Glaucoma Pharmaceutical market is segmented into
Miosis Drugs
Beta-blocker
Adrenergic Agonists
Carbonic Anhydrase Inhibitor
Prostaglandin Derivative Agent
Penetrates

Segment by Application, the Glaucoma Pharmaceutical market is segmented into
Hospital Pharmacy
Drugstore
Online Sales

The Glaucoma Pharmaceutical market is analysed and market size information is provided by regions (countries). Segment by Application, the Glaucoma Pharmaceutical market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Glaucoma Pharmaceutical Market Share Analysis
Glaucoma Pharmaceutical market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glaucoma Pharmaceutical business, the date to enter into the Glaucoma Pharmaceutical market, Glaucoma Pharmaceutical product introduction, recent developments, etc.

The major vendors covered:
Pfizer
Merck
Allergan
Santen
Alcon
Teva Pharmaceuticals
Fera Pharmaceuticals
Bausch & Lomb, Inc.
Akorn, Inc.

レポート目次

1 Glaucoma Pharmaceutical Market Overview
1.1 Glaucoma Pharmaceutical Product Scope
1.2 Glaucoma Pharmaceutical Segment by Type
1.2.1 Global Glaucoma Pharmaceutical Sales by Type (2020-2026)
1.2.2 Miosis Drugs
1.2.3 Beta-blocker
1.2.4 Adrenergic Agonists
1.2.5 Carbonic Anhydrase Inhibitor
1.2.6 Prostaglandin Derivative Agent
1.2.7 Penetrates
1.3 Glaucoma Pharmaceutical Segment by Application
1.3.1 Global Glaucoma Pharmaceutical Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacy
1.3.3 Drugstore
1.3.4 Online Sales
1.4 Glaucoma Pharmaceutical Market Estimates and Forecasts (2015-2026)
1.4.1 Global Glaucoma Pharmaceutical Sales Growth Rate (2015-2026)
1.4.2 Global Glaucoma Pharmaceutical Revenue and Growth Rate (2015-2026)
1.4.3 Global Glaucoma Pharmaceutical Price Trends (2015-2026)

2 Glaucoma Pharmaceutical Estimate and Forecast by Region
2.1 Global Glaucoma Pharmaceutical Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Glaucoma Pharmaceutical Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Glaucoma Pharmaceutical Sales Market Share by Region (2015-2020)
2.2.2 Global Glaucoma Pharmaceutical Revenue Market Share by Region (2015-2020)
2.3 Global Glaucoma Pharmaceutical Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Glaucoma Pharmaceutical Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Glaucoma Pharmaceutical Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Glaucoma Pharmaceutical Estimates and Projections (2015-2026)
2.4.2 Europe Glaucoma Pharmaceutical Estimates and Projections (2015-2026)
2.4.3 China Glaucoma Pharmaceutical Estimates and Projections (2015-2026)
2.4.4 Japan Glaucoma Pharmaceutical Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Glaucoma Pharmaceutical Estimates and Projections (2015-2026)
2.4.6 India Glaucoma Pharmaceutical Estimates and Projections (2015-2026)
3 Global Glaucoma Pharmaceutical Competition Landscape by Players
3.1 Global Top Glaucoma Pharmaceutical Players by Sales (2015-2020)
3.2 Global Top Glaucoma Pharmaceutical Players by Revenue (2015-2020)
3.3 Global Glaucoma Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glaucoma Pharmaceutical as of 2019)
3.4 Global Glaucoma Pharmaceutical Average Price by Company (2015-2020)
3.5 Manufacturers Glaucoma Pharmaceutical Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Glaucoma Pharmaceutical Players (Opinion Leaders)
4 Global Glaucoma Pharmaceutical Market Size by Type
4.1 Global Glaucoma Pharmaceutical Historic Market Review by Type (2015-2020)
4.1.1 Global Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
4.1.2 Global Glaucoma Pharmaceutical Revenue Market Share by Type (2015-2020)
4.1.3 Global Glaucoma Pharmaceutical Price by Type (2015-2020)
4.2 Global Glaucoma Pharmaceutical Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Glaucoma Pharmaceutical Sales Forecast by Type (2021-2026)
4.2.2 Global Glaucoma Pharmaceutical Revenue Forecast by Type (2021-2026)
4.2.3 Global Glaucoma Pharmaceutical Price Forecast by Type (2021-2026)
5 Global Glaucoma Pharmaceutical Market Size by Application
5.1 Global Glaucoma Pharmaceutical Historic Market Review by Application (2015-2020)
5.1.1 Global Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)
5.1.2 Global Glaucoma Pharmaceutical Revenue Market Share by Application (2015-2020)
5.1.3 Global Glaucoma Pharmaceutical Price by Application (2015-2020)
5.2 Global Glaucoma Pharmaceutical Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Glaucoma Pharmaceutical Sales Forecast by Application (2021-2026)
5.2.2 Global Glaucoma Pharmaceutical Revenue Forecast by Application (2021-2026)
5.2.3 Global Glaucoma Pharmaceutical Price Forecast by Application (2021-2026)

6 United States Glaucoma Pharmaceutical Market Facts & Figures
6.1 United States Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
6.2 United States Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
6.3 United States Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)

7 Europe Glaucoma Pharmaceutical Market Facts & Figures
7.1 Europe Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
7.2 Europe Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
7.3 Europe Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)

8 China Glaucoma Pharmaceutical Market Facts & Figures
8.1 China Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
8.2 China Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
8.3 China Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)

9 Japan Glaucoma Pharmaceutical Market Facts & Figures
9.1 Japan Glaucoma Pharmaceutical Sales Market Share by Company (3015-3030)
9.2 Japan Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
9.3 Japan Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)

10 Southeast Asia Glaucoma Pharmaceutical Market Facts & Figures
10.1 Southeast Asia Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)

11 India Glaucoma Pharmaceutical Market Facts & Figures
11.1 India Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
11.2 India Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
11.3 India Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Glaucoma Pharmaceutical Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Glaucoma Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Glaucoma Pharmaceutical Products Offered
12.1.5 Pfizer Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Glaucoma Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Glaucoma Pharmaceutical Products Offered
12.2.5 Merck Recent Development
12.3 Allergan
12.3.1 Allergan Corporation Information
12.3.2 Allergan Business Overview
12.3.3 Allergan Glaucoma Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Allergan Glaucoma Pharmaceutical Products Offered
12.3.5 Allergan Recent Development
12.4 Santen
12.4.1 Santen Corporation Information
12.4.2 Santen Business Overview
12.4.3 Santen Glaucoma Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Santen Glaucoma Pharmaceutical Products Offered
12.4.5 Santen Recent Development
12.5 Alcon
12.5.1 Alcon Corporation Information
12.5.2 Alcon Business Overview
12.5.3 Alcon Glaucoma Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Alcon Glaucoma Pharmaceutical Products Offered
12.5.5 Alcon Recent Development
12.6 Teva Pharmaceuticals
12.6.1 Teva Pharmaceuticals Corporation Information
12.6.2 Teva Pharmaceuticals Business Overview
12.6.3 Teva Pharmaceuticals Glaucoma Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Pharmaceuticals Glaucoma Pharmaceutical Products Offered
12.6.5 Teva Pharmaceuticals Recent Development
12.7 Fera Pharmaceuticals
12.7.1 Fera Pharmaceuticals Corporation Information
12.7.2 Fera Pharmaceuticals Business Overview
12.7.3 Fera Pharmaceuticals Glaucoma Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Fera Pharmaceuticals Glaucoma Pharmaceutical Products Offered
12.7.5 Fera Pharmaceuticals Recent Development
12.8 Bausch & Lomb, Inc.
12.8.1 Bausch & Lomb, Inc. Corporation Information
12.8.2 Bausch & Lomb, Inc. Business Overview
12.8.3 Bausch & Lomb, Inc. Glaucoma Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bausch & Lomb, Inc. Glaucoma Pharmaceutical Products Offered
12.8.5 Bausch & Lomb, Inc. Recent Development
12.9 Akorn, Inc.
12.9.1 Akorn, Inc. Corporation Information
12.9.2 Akorn, Inc. Business Overview
12.9.3 Akorn, Inc. Glaucoma Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Akorn, Inc. Glaucoma Pharmaceutical Products Offered
12.9.5 Akorn, Inc. Recent Development

13 Glaucoma Pharmaceutical Manufacturing Cost Analysis
13.1 Glaucoma Pharmaceutical Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Glaucoma Pharmaceutical
13.4 Glaucoma Pharmaceutical Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Glaucoma Pharmaceutical Distributors List
14.3 Glaucoma Pharmaceutical Customers

15 Market Dynamics
15.1 Glaucoma Pharmaceutical Market Trends
15.2 Glaucoma Pharmaceutical Opportunities and Drivers
15.3 Glaucoma Pharmaceutical Market Challenges
15.4 Glaucoma Pharmaceutical Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Glaucoma Pharmaceutical Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Glaucoma Pharmaceutical Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Glaucoma Pharmaceutical Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Glaucoma Pharmaceutical Sales (K MT) by Region (2015-2020)
Table 5. Global Glaucoma Pharmaceutical Sales Market Share by Region (2015-2020)
Table 6. Global Glaucoma Pharmaceutical Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Glaucoma Pharmaceutical Revenue Share by Region (2015-2020)
Table 8. Global Glaucoma Pharmaceutical Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Glaucoma Pharmaceutical Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Glaucoma Pharmaceutical Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Glaucoma Pharmaceutical Revenue Share Forecast by Region (2021-2026)
Table 12. Global Glaucoma Pharmaceutical (K MT) of Key Companies (2015-2020)
Table 13. Global Glaucoma Pharmaceutical Sales Share by Company (2015-2020)
Table 14. Global Glaucoma Pharmaceutical Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Glaucoma Pharmaceutical Revenue Share by Company (2015-2020)
Table 16. Global Glaucoma Pharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glaucoma Pharmaceutical as of 2019)
Table 17. Global Glaucoma Pharmaceutical Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Glaucoma Pharmaceutical Manufacturing Sites and Area Served
Table 19. Manufacturers Glaucoma Pharmaceutical Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Glaucoma Pharmaceutical Players
Table 22. Global Glaucoma Pharmaceutical Sales (K MT) by Type (2015-2020)
Table 23. Global Glaucoma Pharmaceutical Sales Share by Type (2015-2020)
Table 24. Global Glaucoma Pharmaceutical Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Glaucoma Pharmaceutical Price (K MT) by Type (2015-2020)
Table 26. Global Glaucoma Pharmaceutical Sales Share by Type (2021-2026)
Table 27. Global Glaucoma Pharmaceutical Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Glaucoma Pharmaceutical Revenue Share by Type (2021-2026)
Table 29. Global Glaucoma Pharmaceutical Price (K MT) by Type (2021-2026)
Table 30. Global Glaucoma Pharmaceutical Sales (K MT) by Application (2015-2020)
Table 31. Global Glaucoma Pharmaceutical Sales Share by Application (2015-2020)
Table 32. Global Glaucoma Pharmaceutical Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Glaucoma Pharmaceutical Price (K MT) by Application (2015-2020)
Table 34. Global Glaucoma Pharmaceutical Sales (K MT) by Application (2021-2026)
Table 35. Global Glaucoma Pharmaceutical Sales Share by Application (2021-2026)
Table 36. Global Glaucoma Pharmaceutical Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Glaucoma Pharmaceutical Revenue Share by Application (2021-2026)
Table 38. Global Glaucoma Pharmaceutical Price (K MT) by Application (2021-2026)
Table 39. United States Glaucoma Pharmaceutical Sales (K MT) by Company (2015-2020)
Table 40. United States Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
Table 41. United States Glaucoma Pharmaceutical Sales (K MT) by Type (2015-2020)
Table 42. United States Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
Table 43. United States Glaucoma Pharmaceutical Sales (K MT) by Application (2015-2020)
Table 44. United States Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)
Table 45. Europe Glaucoma Pharmaceutical Sales (K MT) by Company (2015-2020)
Table 46. Europe Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
Table 47. Europe Glaucoma Pharmaceutical Sales (K MT) by Type (2015-2020)
Table 48. Europe Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
Table 49. Europe Glaucoma Pharmaceutical Sales (K MT) by Application (2015-2020)
Table 50. Europe Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
Table 51. China Glaucoma Pharmaceutical Sales (K MT) by Company (2015-2020)
Table 52. China Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
Table 53. China Glaucoma Pharmaceutical Sales (K MT) by Type (2015-2020)
Table 54. China Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
Table 55. China Glaucoma Pharmaceutical Sales (K MT) by Application (2015-2020)
Table 56. China Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)
Table 57. Japan Glaucoma Pharmaceutical Sales (K MT) by Company (2015-2020)
Table 58. Japan Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
Table 59. Japan Glaucoma Pharmaceutical Sales (K MT) by Type (2015-2020)
Table 60. Japan Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
Table 61. Japan Glaucoma Pharmaceutical Sales (K MT) by Application (2015-2020)
Table 62. Japan Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Glaucoma Pharmaceutical Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Glaucoma Pharmaceutical Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Glaucoma Pharmaceutical Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)
Table 69. India Glaucoma Pharmaceutical Sales (K MT) by Company (2015-2020)
Table 70. India Glaucoma Pharmaceutical Sales Market Share by Company (2015-2020)
Table 71. India Glaucoma Pharmaceutical Sales (K MT) by Type (2015-2020)
Table 72. India Glaucoma Pharmaceutical Sales Market Share by Type (2015-2020)
Table 73. India Glaucoma Pharmaceutical Sales (K MT) by Application (2015-2020)
Table 74. India Glaucoma Pharmaceutical Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Glaucoma Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Glaucoma Pharmaceutical Product
Table 79. Pfizer Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Glaucoma Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Merck Glaucoma Pharmaceutical Product
Table 84. Merck Recent Development
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Glaucoma Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Allergan Glaucoma Pharmaceutical Product
Table 89. Allergan Recent Development
Table 90. Santen Corporation Information
Table 91. Santen Description and Business Overview
Table 92. Santen Glaucoma Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Santen Glaucoma Pharmaceutical Product
Table 94. Santen Recent Development
Table 95. Alcon Corporation Information
Table 96. Alcon Description and Business Overview
Table 97. Alcon Glaucoma Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Alcon Glaucoma Pharmaceutical Product
Table 99. Alcon Recent Development
Table 100. Teva Pharmaceuticals Corporation Information
Table 101. Teva Pharmaceuticals Description and Business Overview
Table 102. Teva Pharmaceuticals Glaucoma Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Teva Pharmaceuticals Glaucoma Pharmaceutical Product
Table 104. Teva Pharmaceuticals Recent Development
Table 105. Fera Pharmaceuticals Corporation Information
Table 106. Fera Pharmaceuticals Description and Business Overview
Table 107. Fera Pharmaceuticals Glaucoma Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Fera Pharmaceuticals Glaucoma Pharmaceutical Product
Table 109. Fera Pharmaceuticals Recent Development
Table 110. Bausch & Lomb, Inc. Corporation Information
Table 111. Bausch & Lomb, Inc. Glaucoma Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Bausch & Lomb, Inc. Description and Business Overview
Table 113. Bausch & Lomb, Inc. Glaucoma Pharmaceutical Product
Table 114. Bausch & Lomb, Inc. Recent Development
Table 115. Akorn, Inc. Corporation Information
Table 116. Akorn, Inc. Glaucoma Pharmaceutical Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Akorn, Inc. Description and Business Overview
Table 118. Akorn, Inc. Glaucoma Pharmaceutical Product
Table 119. Akorn, Inc. Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Glaucoma Pharmaceutical Distributors List
Table 123. Glaucoma Pharmaceutical Customers List
Table 124. Glaucoma Pharmaceutical Market Key Trends
Table 125. Glaucoma Pharmaceutical Key Opportunities and Drivers
Table 126. Glaucoma Pharmaceutical Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Glaucoma Pharmaceutical Product Picture
Figure 2. Global Glaucoma Pharmaceutical Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Glaucoma Pharmaceutical Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacy Examples
Figure 7. Drugstore Examples
Figure 8. Online Sales Examples
Figure 9. Global Glaucoma Pharmaceutical Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Glaucoma Pharmaceutical Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Glaucoma Pharmaceutical Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Glaucoma Pharmaceutical Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Glaucoma Pharmaceutical Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Glaucoma Pharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Glaucoma Pharmaceutical Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Glaucoma Pharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Glaucoma Pharmaceutical Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Glaucoma Pharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Glaucoma Pharmaceutical Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Glaucoma Pharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Glaucoma Pharmaceutical Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Glaucoma Pharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Glaucoma Pharmaceutical Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Glaucoma Pharmaceutical Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Glaucoma Pharmaceutical Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Glaucoma Pharmaceutical Players Market Share by Revenue in Glaucoma Pharmaceutical 2015 & 2019
Figure 27. Glaucoma Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Glaucoma Pharmaceutical Revenue Share by Type (2015-2020)
Figure 29. Global Glaucoma Pharmaceutical Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Glaucoma Pharmaceutical Revenue Share by Application (2015-2020)
Figure 31. Global Glaucoma Pharmaceutical Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Glaucoma Pharmaceutical Sales Market Share by Type in 2019
Figure 33. United States Glaucoma Pharmaceutical Sales Market Share by Type in 2019
Figure 34. Europe Glaucoma Pharmaceutical Sales Market Share by Company in 2019
Figure 35. Europe Glaucoma Pharmaceutical Sales Market Share by Type in 2019
Figure 36. Europe Glaucoma Pharmaceutical Sales Market Share by Application in 2019
Figure 37. China Glaucoma Pharmaceutical Sales Market Share by Company in 2019
Figure 38. China Glaucoma Pharmaceutical Sales Market Share by Type in 2019
Figure 39. China Glaucoma Pharmaceutical Sales Market Share by Application in 2019
Figure 40. Japan Glaucoma Pharmaceutical Sales Market Share by Company in 2019
Figure 41. Japan Glaucoma Pharmaceutical Sales Market Share by Type in 2019
Figure 42. Japan Glaucoma Pharmaceutical Sales Market Share by Application in 2019
Figure 43. Southeast Asia Glaucoma Pharmaceutical Sales Market Share by Company in 2019
Figure 44. Southeast Asia Glaucoma Pharmaceutical Sales Market Share by Type in 2019
Figure 45. Southeast Asia Glaucoma Pharmaceutical Sales Market Share by Application in 2019
Figure 46. India Glaucoma Pharmaceutical Sales Market Share by Company in 2019
Figure 47. India Glaucoma Pharmaceutical Sales Market Share by Type in 2019
Figure 48. India Glaucoma Pharmaceutical Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Glaucoma Pharmaceutical
Figure 51. Manufacturing Process Analysis of Glaucoma Pharmaceutical
Figure 52. Glaucoma Pharmaceutical Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed